Johnson & Johnson

Johnson & Johnson's COVID-19 vaccine enters late-stage trial testing

Johnson & Johnson, a COVID-19 vaccine candidate, just began Phase 3 trials in the United States. The company entered its late-stage trial testing.
Read More